Skip to content
Review Open access

ETS transcription factor ELK3: Molecular insights and translational horizons in cancer (Review)

Jul 2026 · Oncology Letters · Vol 32, pp. 1-13 · 0 citations · 106 references
Medicine

TL;DR

The present review summarizes the latest research on the structure of ELK3 and its regulation in normal and tumor tissues, focusing on its primary functions in tumors and the signaling pathways involved.

Abstract

Tumorigenesis is a complex multistage process, with its primary regulatory mechanisms involving the interplay of genetic alterations, immune dysfunction and metabolic abnormalities. Transcription factors serve a crucial role in gene expression regulation, participating in various tumor behaviors such as proliferation, metastasis, angiogenesis and drug resistance. Notably, the abnormal activity of transcription factors is closely associated with cancer initiation and progression, and can promote tumor growth, invasion and therapeutic resistance by regulating angiogenesis, epithelial-mesenchymal transition and metastasis-related gene expression. ELK3 belongs to the ETS transcription factor family and the ternary complex factor subfamily. ELK3 participates in multiple molecular biological processes, and is associated with the initiation, progression, invasion and metastasis of various tumors. The present review summarizes the latest research on the structure of ELK3 and its regulation in normal and tumor tissues, focusing on its primary functions in tumors and the signaling pathways involved. Additionally, the diagnostic value of ELK3 as a biomarker and its potential as a target for tumor-specific therapy are explored.

Read PDF

Similar papers

Review Open access Jul 2026

New insights into the role of TWIST1 in breast cancer progression and metastasis.

Increasing clinical evidence indicates that elevated TWIST1 expression is associated with poor clinical outcomes, higher metastatic burden, and reduced treatment efficacy, emphasizing its importance as a prognostic biomarker and a potential therapeutic target in breast cancer management.

K. Saleh, R. S., P. Nayak et al. · 0 citations
Review Open access Sep 2026

Regulation of tumor angiogenesis: Roles of lncRNAs in molecular signaling, microenvironmental remodeling, and anti-angiogenic therapy.

ABSTRACT Angiogenesis is a crucial step in the growth and metastasis of invasive tumors. Tumor-induced angiogenesis is not due to a single factor; it involves activation of oncogenic signaling pathways and abnormal expression of angiogenesis-related genes within the complex tumor microenvironment (TME). Traditional res...

Xin-Ling Wang, Ying-Ying Zheng, Xi-Wei Wang et al. · 0 citations
Open access Aug 2026

Transcription Factor ELF3 Promotes Cervical Cancer Progression via Transcriptional Upregulation of GMPS

It is demonstrated that ELF3 functions as an oncogenic transcription factor in CC by upregulating GMPS, thereby enhancing proliferation and migration and restraining ferroptosis and targeting the ELF3/GMPS axis represents a promising therapeutic strategy for CC.

Yuan-Yuan Zhang, Shaliya Abuduwufu, Qian Zhuo et al. · 0 citations
Review Open access Sep 2026

From epigenetics to metastasis: Multifaceted roles of lncRNAs in gastric cancer

This review provides a comprehensive overview of the current understanding of lncRNA-mediated regulation of EMT and metastasis in gastric cancer and provides insights into the complex regulatory networks governed by lncRNAs, highlighting their translational potential in improving GC management.

M. Saadh, A. K. Bishoyi, R. Roopashree et al. · 0 citations
Review Sep 2026

SET Oncoprotein in Gastric Cancer: A Master Regulator of PP2A Suppression and Tumor Progression

Therapeutic modulation of the SET-PP2A axis may provide a novel strategy for suppressing tumor progression and improving treatment outcomes, and further mechanistic studies and welldesigned clinical investigations are required to establish the therapeutic relevance of SET targeting and facilitate its integration into p...

Rohit Das, Shikha Yadav, Sudeshna Das et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.